The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies
- 1 February 1986
- journal article
- review article
- Published by Elsevier in Clinics in Haematology
- Vol. 15 (1) , 249-267
- https://doi.org/10.1016/s0308-2261(86)80015-7
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984
- Interleukin 2: the molecule and its functionImmunology Today, 1984
- Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.Journal of Clinical Investigation, 1984
- Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1983
- The mechanism of synergistic complement‐mediated lysis of rat red cells by monoclonal IgG antibodiesEuropean Journal of Immunology, 1983
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Distinctive functional characteristics of human „T”︁ lymphocytes defined by E rosetting or a monoclonal anti‐T cell antibodyEuropean Journal of Immunology, 1981
- Acquired Pure Red-Cell Aplasia Associated with an Increase of T Cells Bearing Receptors for the Fc of IgGActa Haematologica, 1981
- The differentiation and function of human T lymphocytesCell, 1980
- Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiationClinical Immunology and Immunopathology, 1978